NUCALA
NUCALA (mepolizumab) is a monoclonal antibody that helps the body’s immune system by reducing the level of a certain type of white blood cells. Specifically, it is an interleukin-5 (IL-5) antagonist monoclonal antibody (IgG1 kappa) for patients with severe eosinophilic asthma and patients with eosinophilic granulomatosis polyangiitis (EGPA). For more information, visit the patient website […]
FASENRA
FASENRA (benralizumab) is a monoclonal antibody that helps the body’s immune system by reducing the level of a certain type of white blood cells, helping to protect healthy cells from damage. Specifically, it is an interleukin-5 receptor alpha-directed cytolytic monoclonal antibody (IgG1 kappa) used as an add-on maintenance treatment of patients with severe asthma aged […]
CINQAIR
CINQAIR (reslizumab) is a treatment for severe, uncontrolled eosinophilic asthma, and for those whose asthma is not controlled with current asthma medicines and who have high levels of eosinophils. CINQAIR is the only anti-IL-5 with personalized weight-based dosing; weight-based dosing enables your doctor to personalize a dose to you. For more information, visit the patient website […]